Wave Life Sciences Ltd (WVE)
Healthcare
Biotechnology
5.70 $
+4.2%
vs. previous close
Closing price · As of: 3. Aug 2026
Wave Life Sciences Ltd (WVE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -187 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.4 | -13 | -32 | -84 | -23 | -188 | -116 | -89 | -128 | -19 | -151 | -187 | |
| 0.3 | 0.6 | 0.8 | 2.2 | 5.6 | 9.2 | 10.0 | 9.8 | 10 | 9.2 | 8.7 | 8.9 | |
| 0.0 | 4.0 | 6.8 | 12 | 16 | 20 | 14 | 16 | 17 | 9.8 | 13 | 25 | |
| 0.1 | 4.3 | 6.4 | 17 | 16 | 20 | 14 | 16 | 17 | – | – | – | |
| 0.4 | 1.9 | 16 | -0.3 | 102 | -23 | 9.6 | 7.0 | 6.7 | 19 | -76 | -17 | |
| 0.6 | 1.9 | 5.6 | 19 | 9.9 | 3.9 | 1.3 | 0.6 | 1.4 | 1.1 | 0.9 | 0.7 | |
| -0.3 | -2.9 | -8.2 | -19 | -9.9 | -3.9 | -1.3 | -0.6 | -1.3 | -1.1 | -0.9 | -0.7 | |
| – | 113 | 30 | 0.0 | – | – | – | – | – | – | – | – | |
| 5.6 | 176 | 30 | 94 | 65 | 164 | 95 | 56 | 66 | – | – | – | |
| -0.1 | -0.1 | -0.1 | -0.1 | 0.0 | – | – | – | – | – | – | – | |
| 5.6 | 176 | 29 | 94 | 65 | 164 | 155 | 56 | 67 | 133 | 254 | 488 | |
| 0.6 | 160 | -11 | -7.8 | 32 | -28 | 37 | -34 | -62 | 112 | 102 | 300 | |
| -5.0 | -14 | -37 | -103 | -33 | -192 | -117 | -90 | -129 | -21 | -152 | -187 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.